From: Evaluation of pulmonary complications in patients undergoing allogenic stem cell transplantation
 | CMV reactivation/ seroconversion | χ2 | FEp | |||
---|---|---|---|---|---|---|
No (n = 16) | Yes (n = 3) | |||||
No. | % | No. | % | |||
GVHD (n = 19#) | ||||||
 No | 8 | 50.0 | 1 | 33.3 | 0.281 | 1.000 |
 Yes | 8 | 50.0 | 2 | 66.7 | ||
Associated manifestation (n = 19) | ||||||
 No | 6 | 37.5 | 1 | 33.3 | 0.019 | 1.000 |
 Yes | 10 | 62.5 | 2 | 66.7 |